January 30, 2017 — IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced ...
January 17, 2017 — NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of ...
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of ...
January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been ...
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on ...
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected ...
November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s ...
October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the ...
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 ...
October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 ...
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3 ...
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) ...
September 6, 2016 — Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with ...
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
July 12, 2016 — Lantheus Holdings Inc., the parent company of Lantheus Medical Imaging Inc. (LMI), announced the first ...
July 7, 2016 — Cell>Point announced in mid-June it has entered into an exclusive license agreement for China, Hong Kong ...
July 6, 2016 — Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the ...